Javascript must be enabled to continue!
Favipiravir Tautomerism: A Short Theoretical Report
View through CrossRef
There is no experimental data about the tautomerism of Favipiravir (T-705). Therefore its tautomeric state was predicted by using density functional theory in gas phase and in solution (toluene, acetonitrile and water). The solvent effect was described by means of the Polarizable Continuum Model. The results have shown that the enol form is strongly dominating in both gas phase and solution. In order to validate the theoretical predictions, 2-hydroxy pyridine and 2-hydroxy pyrazine were also included in the set of studied compounds. The available experimental data for their tautomerism are in very good agreement with the theoretical predictions, which validate the conclusions made for T-705.
Title: Favipiravir Tautomerism: A Short Theoretical Report
Description:
There is no experimental data about the tautomerism of Favipiravir (T-705).
Therefore its tautomeric state was predicted by using density functional theory in gas phase and in solution (toluene, acetonitrile and water).
The solvent effect was described by means of the Polarizable Continuum Model.
The results have shown that the enol form is strongly dominating in both gas phase and solution.
In order to validate the theoretical predictions, 2-hydroxy pyridine and 2-hydroxy pyrazine were also included in the set of studied compounds.
The available experimental data for their tautomerism are in very good agreement with the theoretical predictions, which validate the conclusions made for T-705.
Related Results
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Quantitative analysis of two COVID-19 antiviral agents, favipiravir and remdesivir, in spiked human plasma using spectrophotometric methods; greenness evaluation
Quantitative analysis of two COVID-19 antiviral agents, favipiravir and remdesivir, in spiked human plasma using spectrophotometric methods; greenness evaluation
AbstractFavipiravir and remdesivir have been included in the COVID-19 treatment guidelines panel of several countries. The main objective of the current work is to develop the firs...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Toward a Comprehensive Treatment of Tautomerism in Chemoinformatics Including in InChI V2
Toward a Comprehensive Treatment of Tautomerism in Chemoinformatics Including in InChI V2
We have collected 86 different transforms of tautomeric interconversions. Out of those, 54 are for prototropic (non-ring-chain) tautomerism; 21 for ring-chain tautomerism; and 11 f...
Chest Wall Hydatid Cysts: A Systematic Review
Chest Wall Hydatid Cysts: A Systematic Review
Abstract
Introduction
Given the rarity of chest wall hydatid disease, information on this condition is primarily drawn from case reports. Hence, this study systematically reviews t...
Structural basis of SARS-CoV-2 polymerase inhibition by Favipiravir
Structural basis of SARS-CoV-2 polymerase inhibition by Favipiravir
AbstractThe outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has developed into an unprecedented global pandemic. Nucleoside analogues, such as Remdesivir a...
Tautomer Database: A Comprehensive Resource for Tautomerism Analyses
Tautomer Database: A Comprehensive Resource for Tautomerism Analyses
We report a database of tautomeric structures that contains 2,819 tautomeric tuples extracted from 171 publications. Each tautomeric entry has been annotated with experimental cond...
FAVIPIRAVIR EFFICACY AND SAFETY FOR THE TREATMENT OF SEVERE CORONAVIRUS 2019. A RETROSPECTIVE STUDY.
FAVIPIRAVIR EFFICACY AND SAFETY FOR THE TREATMENT OF SEVERE CORONAVIRUS 2019. A RETROSPECTIVE STUDY.
Background: Corona virus disease is caused by the enveloped, single stranded RNA virus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) becoming the deadliest ...

